NEJM – Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

felipebatalini

Current Internal Medicine resident at Boston University Medical Center, future Hematology and Oncology fellow at Beth Israel Deaconess Medical Center, Harvard Medical School.

You may also like...

Leave a Reply

%d bloggers like this: